Olympic Steel Inc (ZEUS) 28.66 $ZEUS U.S. Steel (X) Q2

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 8:21 AM

Olympic Steel Inc (ZEUS) 28.66 $ZEUS

U.S. Steel (X) Q2 Loss Lower than Expected, Sales Miss
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 7:46AM CDT
U.S. Steel (X) reported a narrower loss of $46 million or 32 cents per share in the second quarter of 2016.
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), X: 27.49 (+0.59), MT: 6.52 (+0.37)

Allegheny (ATI) Q2 Loss Lower than Expected, Sales Beat
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 1:10PM CDT
Allegheny Technologies Inc. (ATI) reported an adjusted loss of 21 cents per share in second-quarter 2016.
ATI: 17.81 (-0.09), RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37)

4 Strong Buy-Ranked Steel Producers
Adam Clark - Zacks Investment Research - Mon Jul 25, 11:29AM CDT
The Steel Producer Industry has had a great year thus far in 2016, with several stocks in the group seeing large double- and triple-digit gains. The industry is still ranked in the top 4% of all industries ranked by Zacks, and we've highlighted 4 stocks that currently hold a Zacks Rank #1 (Strong Buy).
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), SCHN: 19.49 (-0.02), MT: 6.52 (+0.37)

AK Steel's (AKS) Shares Touch Fresh 52-Week High at $5.52
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:40AM CDT
Shares of AK Steel (AKS) touched a new 52-week high of $5.52 on Jul 13.
ZEUS: 28.66 (+0.15), SCHN: 19.49 (-0.02), AKS: 6.56 (+0.06), MT: 6.52 (+0.37)

Is Olympic Steel (ZEUS) Stock a Solid Choice Right Now?
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:35AM CDT
Olympic Steel is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective.
ZEUS: 28.66 (+0.15)

The Zacks Analyst Blog Highlights: Axiall, B2Gold, Compania de Minas Buenaventura S.A.A., McEwen Mining and Olympic Steel
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 8:30AM CDT
The Zacks Analyst Blog Highlights: Axiall, B2Gold, Compania de Minas Buenaventura S.A.A., McEwen Mining and Olympic Steel
BTG: 3.13 (+0.12), ZEUS: 28.66 (+0.15), AXLL: 32.65 (+0.04), BVN: 14.65 (+0.50), MUX: 4.44 (+0.19)

5 Basic Materials Stocks to Buy on Strong Momentum
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 3:52PM CDT
We suggest five momentum stocks in the materials space right now which exhibit all signs of healthy prospects.
AA: 10.62 (-0.06), BTG: 3.13 (+0.12), AXLL: 32.65 (+0.04), ZEUS: 28.66 (+0.15), BVN: 14.65 (+0.50), MUX: 4.44 (+0.19)

AK Steel Ups Specialty Sheet & Strip Stainless Steel Prices
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 4:43PM CDT
AK Steel Holding Corporation (AKS) declared that it will raise base prices for all specialty sheet and strip stainless steel products by 3%-6%.
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), AKS: 6.56 (+0.06), MT: 6.52 (+0.37)

AK Steel Closes Offering of $380M Senior Secured Notes
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:38AM CDT
AK Steel holding Corporation (AKS) said that its subsidiary, AK Steel Corporation, has successfully closed the registered offering of $380 million aggregate principal amount of 7.50% senior secured notes due 2023.
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), AKS: 6.56 (+0.06), MT: 6.52 (+0.37)

POSCO's Long-term Potential Solid, Runs Near-Term Risks
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:44AM CDT
We issued an updated research report on South Korean steel producer POSCO (PKX) on Jun 21, 2016.
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37), PKX: 50.68 (+0.16)

Companhia Siderurgica's Future Dim on Micro & Macro Woes
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 6:07AM CDT
We issued an updated research report on Companhia Siderurgica Nacional (SID) or CSN on Jun 17, 2016.
SID: 3.39 (-0.04), RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), PKX: 50.68 (+0.16)

Surging Earnings Estimates Signal Good News for Olympic Steel (ZEUS)
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:39AM CDT
Olympic Steel (ZEUS) could be good choice for investors as it is seeing decent short-term momentum and positive earnings estimate revisions.
ZEUS: 28.66 (+0.15)

Shiloh Industries' (SHLO) Q2 Earnings Fall Y/Y, Revenues Up
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 10:28AM CDT
Shiloh Industries Inc. (SHLO) reported adjusted earnings of 19 cents per share for second-quarter fiscal 2016 (ended Apr 30, 2016), below earnings of 40 cents in the year-ago quarter. Net revenues grew 4.4% to $284.3 million.
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), SHLO: 9.69 (+0.08), MT: 6.52 (+0.37)

LB Foster's Exposure to Price Fluctuations Raises Concerns
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 9:27AM CDT
On Jun 7, 2016, we issued an updated research report on premium railroads manufacturing firm LB Foster Co. (FSTR).
FSTR: 10.48 (+0.28), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37)

Nucor Poised on Auto Momentum, Expansion Amid Headwinds
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:21AM CDT
We have issued an updated research report on steel giant Nucor (NUE).
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), NUE: 53.64 (-0.17), MT: 6.52 (+0.37)

Allegheny (ATI) Declares Pricing of Senior Notes Offering
Zacks Equity Research - Zacks Investment Research - Fri May 20, 6:50AM CDT
Allegheny Technologies Inc. (ATI) has declared the pricing of its public offering of convertible senior notes.
ATI: 17.81 (-0.09), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37), PKX: 50.68 (+0.16)

ArcelorMittal Delivers Steel to World's Largest Cruise Ship
Zacks Equity Research - Zacks Investment Research - Thu May 19, 8:18AM CDT
ArcelorMittal's (MT) sites in Spain and France have provided all the steel that has been used in the Harmony of the Seas, the world's largest cruise ship, which is also being considered as Europe's biggest hotel.
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37), PKX: 50.68 (+0.16)

Allegheny Exposed to Flat-Rolled Challenges, Pricing Woes
Zacks Equity Research - Zacks Investment Research - Thu May 19, 5:31AM CDT
We have issued an updated research report on Allegheny Technologies (ATI).
ATI: 17.81 (-0.09), RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37)

Allegheny Technologies (ATI) Declares Senior Notes Offering
Zacks Equity Research - Zacks Investment Research - Wed May 18, 6:45AM CDT
Allegheny Technologies Incorporated (ATI) has declared its plans to offer a series of convertible senior notes, subject to market and other conditions.
ATI: 17.81 (-0.09), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37), PKX: 50.68 (+0.16)

ArcelorMittal (MT) Gets Government Grant for LNG Project
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:40AM CDT
Steel giant ArcelorMittal (MT) announced that ArcelorMittal Mining Canada has been awarded a C$4.5 million grant from the Quebec government which will allow its pellet plant to use a greater proportion of alternative fuels.
RYI: 14.44 (-0.02), ZEUS: 28.66 (+0.15), MT: 6.52 (+0.37), PKX: 50.68 (+0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...